Physician profile
Jason Smith
NPI 1831272756
$578.11
in general payments reported to CMS, 2019-2025
17 companies · $68.63 in 2025
The $68.63 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $89.13 · 2021: $84.31 · 2022: $32.93 · 2023: $89.55 · 2024: $63.79 · 2025: $68.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $221.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $198.62 | 2019-2025 | Bexsero |
| Ironshore Pharmaceuticals INC. | $67.28 | 2020-2024 | |
| Tris Pharma INC | $41.71 | 2021-2025 | Dyanavel Xr |
| Astrazeneca Pharmaceuticals LP | $32.10 | 2023-2024 | Flumist Quadrivalent |
| Corium, LLC | $27.20 | 2022-2025 | Azstarys |
| Pfizer INC. | $26.47 | 2019 | |
| Cranial Technologies, INC | $23.73 | 2020 | |
| Novartis Pharmaceuticals Corporation | $22.99 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.97 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $20.44 | 2021 | |
| Collegium Pharmaceutical, INC. | $16.27 | 2025 | Jornay Pm |
| Sun Pharmaceutical Industries INC. | $15.46 | 2023 | Ilumya |
| Sanofi Pasteur INC. | $14.44 | 2023 | |
| Supernus Pharmaceuticals, INC. | $13.10 | 2021 | |
| Mission Pharmacal Company | $12.84 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $11.47 | 2019 | |
| Aytu Biopharma, INC. | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.